Market cap
₹26 Cr
Revenue (TTM)
₹5 Cr
P/E Ratio
65.9
P/B Ratio
2.6
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹0 Cr
-
ROE
2.6 %
-
ROCE
2.7 %
-
Industry P/E
50.18
-
EV/EBITDA
51.8
-
Debt to Equity
0
-
Book Value
₹15.8
-
EPS
₹0.6
-
Face value
10
-
Shares outstanding
6,272,629
10 Years Aggregate
CFO
₹17.48 Cr
EBITDA
₹-10.48 Cr
Net Profit
₹4.44 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Pentokey Organy
| 1.0 | 14.2 | -4.2 | 4.9 | -2.8 | 18.2 | -- |
|
BSE Healthcare
| 8.8 | 8.8 | 9.7 | 11.0 | 27.5 | 14.1 | 12.0 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
|---|---|---|---|---|---|
|
Pentokey Organy
| -17.1 | -55.1 | 378.5 | -1.9 | 281.5 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Pentokey Organy
|
41.0 | 25.7 | 4.6 | 0.4 | 1.7 | 4 | 65.9 | 2.6 |
| 3,107.5 | 38,804.4 | 5,452.9 | 1,056.0 | 22.4 | 23.9 | 36.7 | 8.6 | |
| 1,713.6 | 32,463.4 | 9,203.5 | 941.3 | 15.4 | 19.6 | 35.1 | 6.6 | |
| 1,354.4 | 5,886.6 | 6,020.3 | 132.1 | 3.2 | 6.8 | 52.2 | 3.3 | |
| 2,192.6 | 35,263.5 | 4,147.8 | 709.5 | 22.3 | 18.3 | 49.7 | 8.5 | |
| 43.6 | 19.2 | 25.3 | 0.1 | 0.4 | 2.5 | 168.3 | 4.0 | |
| 26.2 | 32.7 | 12.5 | -3.0 | -90.2 | -2.7 | -- | 0.3 | |
| 45.7 | 25.0 | 294.6 | 2.1 | 0.9 | 163.8 | 12.2 | 9.8 | |
| 1.8 | 7.1 | 115.9 | 0.4 | 0.6 | 8.9 | 18 | 1.6 | |
| 0.3 | 35.8 | 386.8 | 35.4 | 11.1 | 29.9 | 1 | 0.2 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Pentokey Organy
Pentokey Organy (India) Limited trades in organic chemicals. Its products include acetic acid, ethyl acetate, acetaldehyde, and butyl acetate. Pentokey Organy (India) Limited was incorporated in 1986 and is headquartered in Mumbai, India.
-
Incorporated
1986
-
Chairman
--
-
Managing Director
--
-
Headquarters
Mumbai, Maharashtra
-
Website
Looking for more details about Pentokey Organy (India) Ltd.’s IPO? Explore our IPO Details page.
Annual Reports
Announcements
View AnnouncementsNo News & Announcements are available.
FAQs for Pentokey Organy
What is the current share price of Pentokey Organy (India) Ltd Today?
The share price of Pentokey Organy (India) Ltd is ₹40.99 (BSE) as of 22-May-2026 IST. Pentokey Organy (India) Ltd has given a return of -2.81% in the last 3 years.
What is the current PB & PE ratio of Pentokey Organy (India) Ltd?
The P/E ratio of Pentokey Organy (India) Ltd is 65.93 times as on 22-May-2026, a 31 premium to its peers’ median range of 50.18 times.
The P/B ratio of Pentokey Organy (India) Ltd is 2.59 times as on 22-May-2026, a 793 premium to its peers’ median range of 0.29 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
80.86
|
2.10
|
|
2024
|
40.26
|
3.79
|
|
2023
|
8.19
|
3.11
|
|
2022
|
0.00
|
2.18
|
|
2021
|
0.00
|
1.27
|
What is the 52 Week High and Low of Pentokey Organy (India) Ltd?
The 52-week high and low of Pentokey Organy (India) Ltd are Rs 57.00 and Rs 28.49 as of 22-May-2026.
What is the market cap of Pentokey Organy (India) Ltd?
Pentokey Organy (India) Ltd has a market capitalisation of ₹ 26 Cr as on 22-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Pentokey Organy (India) Ltd?
Before investing in Pentokey Organy (India) Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.